4 ml

DRUG3 trials

Sponsors

Institut Gustave Roussy, Hopital Fondation Adolphe De Rothschild, Centre Hospitalier Universitaire D'Angers

Conditions

Lower limb trauma requiring immobilisationPatient with severe eye chemical burnsThromboprophylaxis in good and intermediate prognosis advanced germ cell tumors

Phase 2

SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre, single-arm, open-label phase II trial

Not yet recruitingCTIS2023-509713-37-00

Hopital Fondation Adolphe De RothschildPatient with severe eye chemical burns

Target: 21Updated: 2025-12-09

Phase 3

Thromboprophylaxis in good and intermediate prognosis advanced germ cell tumors (GIG-T)

RecruitingCTIS2022-502426-41-00

Institut Gustave RoussyThromboprophylaxis in good and intermediate prognosis advanced germ cell tumors

Start: 2023-10-17Target: 387Updated: 2026-01-13

RIVACAST - RIVAroxaban versus low-molecular weight heparin in patients with lower limb trauma requiring brace or CASTing

RecruitingCTIS2023-509905-62-00

Centre Hospitalier Universitaire D'AngersLower limb trauma requiring immobilisation

Start: 2024-07-19Target: 1424Updated: 2025-10-06